Year: 2021

news_6

HighTide Therapeutics Announces the Presentation of Topline Results of Phase 2 Study of HTD1801 in PSC Patients at the International Liver Congress 2021

SHENZHEN, China & ROCKVILLE, Md.--(BUSINESS WIRE)--HighTide Therapeutics Inc. (“HighTide”), a clinical-stage biopharmaceutical company, today announced the topline results of the...

news_6

Legacy Education Alliance, Inc. Urges Eligible Stockholders to Vote Their Proxies for the Annual Meeting of Stockholders by July 1, 2021

CAPE CORAL, Fla.--(BUSINESS WIRE)--$LEAI--Legacy Education Alliance, Inc. (OTCQB: LEAI) (www.legacyeducationalliance.com), a leading marketer of practical, high-quality, and value-based educational training...